Uso del Cell Saver en la cirugía cardiaca

A randomized controlled trial of cell salvage in r...[Anesth Analg. 2008] - PubMed Result:
"CONCLUSION: In patients undergoing routine first-time cardiac surgery in an institution with a rigorous blood conservation program, the routine use of cell salvage does not further reduce the proportion of patients exposed to allogeneic blood transfusion. However, patients who do not have excessive bleeding after surgery receive significantly fewer units of blood with cell salvage. Although the use of cell savage may reduce the demand for blood products during cardiac surgery, this comes at an increased cost to the institution."

Transfusión sanguínea en cirugía cardiaca. Actualización

Transfusion dependency of cardiac surgery--update ...[Swiss Med Wkly. 2006] - PubMed Result
Descripción de las técnicas empleadas para la disminución del uso de sangre homóloga en la cirugía cardiaca, llegando a requerir solamente 2 paquetes globulares.

Eficacia de una sola amp de eritropoyetina en el preoperatorio

The efficacy of preoperative administration of a single dose of recombinant human erythropoietin...[Heart Surg Forum. 2007] - PubMed Result
CONCLUSIONS: Although the effectiveness for avoiding transfusion was not clear, the administration of a single dose of rHuEPO without autologous blood donations had an effect by increasing hematocrit levels.